This article summarizes recent developments in the health sector, including major acquisitions, drug trial results, and ...

RK Asset Management boosted its stake in Regeneron Pharmaceuticals by 25.8%, bringing its total to 12,563 shares worth $7.97 ...

Fintel reports that on May 30, 2025, Wells Fargo downgraded their outlook for Regeneron Pharmaceuticals (NasdaqGS:REGN) from ...

Analysts have set 12-month price targets for Regeneron Pharmaceuticals, revealing an average target of $808.67, a high ...

Regeneron and Sanofi face setbacks as itepekimab stumbles in phase 3. Click here to read why I believe SNY and REGN stocks ...

Federal jurors in Delaware found that Amgen violated antitrust laws by bundling its cholesterol treatment with substantial ...

Williams Jones Wealth Management reduced its Regeneron Pharmaceuticals holdings by 39.4% in the fourth quarter, unloading 715 ...

Tarrytown-based Regeneron Pharmaceuticals, Inc. has been named the successful bidder in the bankruptcy auction for substantially all of the assets of ...

Federal jurors in Delaware found that Amgen violated antitrust laws by bundling its cholesterol treatment with substantial ...

Tarrytown-based Regeneron Pharmaceuticals, Inc. has announced it has been named the successful bidder in the bankruptcy ...

A seminal decision concerning second medical use patents and questions over confidentiality were among the top talking points ...